Healthcare provider profile · identity verified

Joomo Yang, M.D.

Internal Medicine · CALABASAS, CA · NPI 1619954898

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	500	106
Atorvastatin Calcium	Atorvastatin Calcium	428	93
Eliquis	Apixaban	413	84
Escitalopram Oxalate	Escitalopram Oxalate	335	63
Amlodipine Besylate	Amlodipine Besylate	256	66
Tamsulosin Hcl	Tamsulosin Hcl	248	50
Furosemide	Furosemide	238	57
Donepezil Hcl	Donepezil Hcl	223	35
Gabapentin	Gabapentin	215	49
Divalproex Sodium	Divalproex Sodium	208	37
Mirtazapine	Mirtazapine	182	38
Potassium Chloride	Potassium Chloride	182	45
Trazodone Hcl	Trazodone Hcl	171	38
Quetiapine Fumarate	Quetiapine Fumarate	170	39
Metoprolol Tartrate	Metoprolol Tartrate	161	34
Lisinopril	Lisinopril	158	32
Sertraline Hcl	Sertraline Hcl	158	27
Losartan Potassium	Losartan Potassium	156	38
Memantine Hcl	Memantine Hcl	154	33
Rosuvastatin Calcium	Rosuvastatin Calcium	124	22
Clopidogrel	Clopidogrel Bisulfate	116	21
Pantoprazole Sodium	Pantoprazole Sodium	116	31
Duloxetine Hcl	Duloxetine Hcl	114	18
Simvastatin	Simvastatin	111	21
Metoprolol Succinate	Metoprolol Succinate	110	29
Finasteride	Finasteride	107	19
Xarelto	Rivaroxaban	88	16
Alprazolam	Alprazolam	87	27
Carvedilol	Carvedilol	85	24
Myrbetriq	Mirabegron	85	13
Risperidone	Risperidone	83	17
Lorazepam	Lorazepam	78	25
Famotidine	Famotidine	76	17
Omeprazole	Omeprazole	75	21
Latanoprost	Latanoprost	73	21
Midodrine Hcl	Midodrine Hcl	71	17
Temazepam	Temazepam	69	16
Digoxin	Digoxin	68	17
Tramadol Hcl	Tramadol Hcl	68	24
Clonazepam	Clonazepam	65	suppressed
Spironolactone	Spironolactone	65	13
Montelukast Sodium	Montelukast Sodium	64	13
Metformin Hcl	Metformin Hcl	56	17
Levetiracetam	Levetiracetam	53	12
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	52	13
Fluticasone Propionate	Fluticasone Propionate	51	15
Citalopram Hbr	Citalopram Hydrobromide	50	12
Alendronate Sodium	Alendronate Sodium	47	suppressed
Hydralazine Hcl	Hydralazine Hcl	47	12
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	47	20
Bumetanide	Bumetanide	46	15
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	45	40
Celecoxib	Celecoxib	44	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	43	20
Carbidopa-Levodopa	Carbidopa/Levodopa	41	13
Ezetimibe	Ezetimibe	39	suppressed
Amiodarone Hcl	Amiodarone Hcl	38	suppressed
Methenamine Hippurate	Methenamine Hippurate	38	suppressed
Allopurinol	Allopurinol	37	suppressed
Nystatin	Nystatin	37	16
Estradiol	Estradiol	35	suppressed
Linzess	Linaclotide	35	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	34	suppressed
Lovastatin	Lovastatin	33	suppressed
Synthroid	Levothyroxine Sodium	33	11
Zolpidem Tartrate	Zolpidem Tartrate	33	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	32	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	32	26
Ciprofloxacin Hcl	Ciprofloxacin Hcl	30	26
Hydrochlorothiazide	Hydrochlorothiazide	30	suppressed
Bupropion Xl	Bupropion Hcl	29	suppressed
Entresto	Sacubitril/Valsartan	29	suppressed
Warfarin Sodium	Warfarin Sodium	29	suppressed
Clonidine Hcl	Clonidine Hcl	28	suppressed
Creon	Lipase/Protease/Amylase	28	suppressed
Rivastigmine	Rivastigmine	28	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	28	suppressed
Baclofen	Baclofen	27	suppressed
Flecainide Acetate	Flecainide Acetate	27	suppressed
Lactulose	Lactulose	27	suppressed
Buspirone Hcl	Buspirone Hcl	26	suppressed
Prednisone	Prednisone	26	11
Albuterol Sulfate Hfa	Albuterol Sulfate	25	14
Benazepril Hcl	Benazepril Hcl	24	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	24	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	24	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	24	suppressed
Pravastatin Sodium	Pravastatin Sodium	23	suppressed
Divalproex Sodium Er	Divalproex Sodium	22	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	22	suppressed
Liothyronine Sodium	Liothyronine Sodium	22	suppressed
Meloxicam	Meloxicam	22	suppressed
Azithromycin	Azithromycin	21	19
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	21	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	21	suppressed
Timolol Maleate	Timolol Maleate	21	suppressed
Atenolol	Atenolol	20	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	20	suppressed
Febuxostat	Febuxostat	20	suppressed
Hydroxyurea	Hydroxyurea	20	suppressed
Levofloxacin	Levofloxacin	20	18
Ondansetron Odt	Ondansetron	20	18
Cephalexin	Cephalexin	19	14
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	19	suppressed
Lacosamide	Lacosamide	19	suppressed
Solifenacin Succinate	Solifenacin Succinate	19	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	19	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	19	suppressed
Aripiprazole	Aripiprazole	18	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	18	suppressed
Irbesartan	Irbesartan	18	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	18	suppressed
Lumigan	Bimatoprost	18	suppressed
Metformin Hcl Er	Metformin Hcl	18	suppressed
Methimazole	Methimazole	18	suppressed
Metolazone	Metolazone	18	suppressed
Ozempic	Semaglutide	18	suppressed
Valsartan	Valsartan	18	suppressed
Cholestyramine	Cholestyramine (With Sugar)	17	suppressed
Ezetimibe-Simvastatin	Ezetimibe/Simvastatin	17	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	17	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	17	suppressed
Pregabalin	Pregabalin	17	suppressed
Acyclovir	Acyclovir	16	suppressed
Diclofenac Sodium	Diclofenac Sodium	16	suppressed
Farxiga	Dapagliflozin Propanediol	15	suppressed
Lamotrigine	Lamotrigine	15	suppressed
Ondansetron Hcl	Ondansetron Hcl	15	suppressed
Prednisolone Acetate	Prednisolone Acetate	15	suppressed
Trulicity	Dulaglutide	15	suppressed
Belsomra	Suvorexant	14	suppressed
Chlorthalidone	Chlorthalidone	14	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	14	suppressed
Fentanyl	Fentanyl	14	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	14	suppressed
Folic Acid	Folic Acid	14	suppressed
Glycopyrrolate	Glycopyrrolate	14	suppressed
Memantine Hcl Er	Memantine Hcl	14	suppressed
Methylprednisolone	Methylprednisolone	14	13
Propranolol Hcl Er	Propranolol Hcl	14	suppressed
Sucralfate	Sucralfate	14	suppressed
Telmisartan	Telmisartan	14	suppressed
Ventolin Hfa	Albuterol Sulfate	14	suppressed
Azelastine Hcl	Azelastine Hcl	13	suppressed
Cefdinir	Cefdinir	13	12
Clotrimazole	Clotrimazole	13	suppressed
Dutasteride	Dutasteride	13	suppressed
Erythromycin	Erythromycin Base	13	suppressed
Lansoprazole	Lansoprazole	13	suppressed
Methotrexate	Methotrexate Sodium	13	suppressed
Nebivolol Hcl	Nebivolol Hcl	13	suppressed
Symbicort	Budesonide/Formoterol Fumarate	13	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	12	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	12	suppressed
Lamotrigine Er	Lamotrigine	12	suppressed
Olmesartan-Amlodipine-Hctz	Olmesartan/Amlodipin/Hcthiazid	12	suppressed
Topiramate	Topiramate	12	suppressed
Eplerenone	Eplerenone	11	suppressed
Fenofibrate	Fenofibrate	11	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	11	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	11	suppressed
Olanzapine	Olanzapine	11	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	11	suppressed
Oxycodone Hcl	Oxycodone Hcl	11	suppressed
Paroxetine Hcl	Paroxetine Hcl	11	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	11	suppressed
Ramipril	Ramipril	11	suppressed
Rhopressa	Netarsudil Mesylate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error